NDC 48951-8002-01 - Pancreas Equisetum
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48951-8002
- Requested NDC
- 48951-8002-01
- Package NDCs from labels
- 48951-8002-1, 48951-8002-01
- Manufacturer
- Uriel Pharmacy Inc.
- Effective date
- 2026-02-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pancreas Equisetum | Uriel Pharmacy Inc. | 2026-02-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 48951-8002-1 | Pancreas Equisetum | 1 mL in 1 AMPULE | LIQUID | 1 | 6 | |
| 48951-8002-1 | Pancreas Equisetum | 10 in 1 BOX | LIQUID | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 48951-8002 | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250129_7920248d-bb69-4403-8b79-1a60c4c70db6.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| EQUISETUM ARVENSE TOP | ACTIVE INGREDIENT | 1DP6Y6B65Z | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| QUERCUS ROBUR WHOLE | ACTIVE INGREDIENT | R7QMG0BT2W | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| SUS SCROFA PANCREAS | ACTIVE INGREDIENT | 9Y3J3362RY | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| EQUISETUM ARVENSE TOP | ACTIVE MOIETY | 1DP6Y6B65Z | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| QUERCUS ROBUR WHOLE | ACTIVE MOIETY | R7QMG0BT2W | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| SUS SCROFA PANCREAS | ACTIVE MOIETY | 9Y3J3362RY | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PANCREAS EQUISETUM LIQUID [URIEL PHARMACY INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Female Vitality T010 | CIMICIFUGA RACEMOSA, FUCUS VESICULOSUS, OOPHORINUM (SUIS), HYPOPHYSIS SUIS, THYROIDINUM (SUIS), GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), SEPIA | Guangzhou Renuma Medical Systems Co., Ltd | 694f0c36-b656-471a-9f38-2efb5193e05a | 2017-10-20 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Company | 886f889b-f3cf-4197-b307-6cfa88c89436 | 2017-05-04 | 451W47IQ8X | |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corp | 9883c502-9782-451e-9eec-c54d7b054f31 | 2017-01-31 | Warnings | 451W47IQ8X |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM | Energetix Corp | 6b0d1628-b20d-426e-9c84-5cceadca3f45 | 2016-11-11 | Warnings | 451W47IQ8X |
| Diathesis V 1 | GINKGO BILOBA, PANCREAS (SUIS), SPLEEN (SUIS), STOMACH (SUIS), GERMANIUM SESQUIOXIDE, CUPRUM METALLICUM, CYSTEINUM, ZINCUM METALLICUM, MANGANESE GLUCONATE, ALPHA-KETOGLUTARICUM ACIDUM, FUMARICUM ACIDUM, NATRUM OXALACETICUM | BioActive Nutritional, Inc. | 58a16fcf-b05f-41a9-a580-41da6300ac7f | 2016-11-04 | Warnings | 9Y3J3362RY |
| Weight Management Support | ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), CEREBRUM (SUIS), HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, PANCREAS SUIS, STOMACH (SUIS), AACG-A, AACG-B, CALCAREA CARBONICA, GAMBOGIA, GELSEMIUM SEMPERVIRENS, GRAPHITES, NUX VOMICA, PHYTOLACCA DECANDRA, 7-KETO (3-ACETYL-7-OXO-DEHYDROEPIANDROSTERONE), ADENOSINUM TRIPHOSPHORICUM DINATRUM, GLUCAGON, INSULINUM, SARCOLACTICUM ACIDUM, PROTEUS (VULGARIS) | Lifetime Fat Loss Centers | 940ca77c-2f80-4457-a31d-08dc70e89805 | 2016-06-23 | Warnings | 9Y3J3362RY |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.